Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00161668 · ClinicalTrials.gov registry record
Study Evaluating Mylotarg (Gemtuzumab Ozogamicin) in Usual Care
A clinical trial, sponsored by Wyeth is now a wholly owned subsidiary of Pfizer.
- Completed
- Registry status
- 500
- Enrollment target
NCT00161668 is a clinical trial that has completed, run by Wyeth is now a wholly owned subsidiary of Pfizer. The registered enrollment target is 500 participants.
The verdict
NCT00161668 has completed, sponsored by Wyeth is now a wholly owned subsidiary of Pfizer.
- COMPLETED
- Registry status
- 500 participants
- Enrollment target
Study Summary
This study is designed to assess the safety of Mylotarg therapy in routine practice.
Interventions
- DRUG Mylotarg
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 500 participants |
| Start Date | 2001-10 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00161668
The ClinicalTrials.gov registry entry for NCT00161668 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 500 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wyeth is now a wholly owned subsidiary of Pfizer, which has 167 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Mylotarg is the first listed.
NCT00161668 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00161668 about?
NCT00161668 is a clinical study titled "Study Evaluating Mylotarg (Gemtuzumab Ozogamicin) in Usual Care". This study is designed to assess the safety of Mylotarg therapy in routine practice.
What is the current status of trial NCT00161668?
This trial is currently completed. The enrollment target is 500 participants. The study started on 2001-10.
What interventions are being tested in trial NCT00161668?
The interventions under investigation include: Mylotarg (DRUG).
Who is sponsoring clinical trial NCT00161668?
This trial is sponsored by Wyeth is now a wholly owned subsidiary of Pfizer, which has 167 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.